A BRISTOL TENNESSEE-BASED DRUG COMPANY IS SELLING OFF PART OF ITS ASSETS. DRUGMAKER KING PHARMACEUTICALS IS DIVERSING ITSELF OF ITS MANUFACTURING PLANT IN MICHIGAN. THE BUYER IS A NEW JERSEY-BASED PHARMACEUTICAL COMPANY. ACCORDING TO KING OFFICIALS, KING WILL SELL ITS ROCHESTER PLANT TO SADDLE RIVER-BASED JHP PHARMACEUTICALS FOR 90 MILLION DOLLARS. THE MOVE IS EXPECTED TO CREATE GREATER OPERATING EFFICIENCY WITHIN KING.